Gehan Ea
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
Papers in
-
- Acute Lymphoblastic Leukemia research 4
-
- Acute Myeloid Leukemia Research 4
- Hematopoietic Stem Cell Transplantation 2
- Co-authors
- EJ Freireich (4 shared papers)KB McCredie (4 shared papers)Terry Smith (2 shared papers)Gary Spitzer (1 shared paper)Burgert Eo (1 shared paper)Melvin Tefft (1 shared paper)Pritchard Dj (1 shared paper)John M. Kissane (1 shared paper)
- Journals
- Blood (4 papers)PubMed (4 papers)
- Partner nations
- United States
In The Last Decade
Gehan Ea
8 papers receiving 324 citations
Peers
Comparison fields: 5 of 40
- Hematology 187
- Genetics 45
- Pulmonary and Respiratory Medicine 124
- Public Health, Environmental and Occupational Health 90
- Emergency Medicine 23
Countries citing papers authored by Gehan Ea
This map shows the geographic impact of Gehan Ea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gehan Ea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gehan Ea more than expected).
Fields of papers citing papers by Gehan Ea
This network shows the impact of papers produced by Gehan Ea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gehan Ea. The network helps show where Gehan Ea may publish in the future.
Co-authors
The 16 scholars most cited alongside Gehan Ea, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1976 | 92 | |
| 2 | Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: an Intergroup Study. | 1981 | 78 |
| 3 | 1976 | 74 | |
| 4 | Multidrug adjuvant chemotherapy for osteosarcoma: interim report of the Southwest Oncology Group Studies. | 1978 | 47 |
| 5 | 1980 | 46 | |
| 6 | Evaluation of intensified chemotherapy in children with advanced rhabdomyosarcoma (clinical groups III and IV). The Intergroup Rhabdomyosarcoma Study (IRS) Committee of the Cancer and Leukemia Group B Children's Cancer Study Group, Southwest Oncology Group. | 1979 | 11 |
| 7 | 1980 | 3 | |
| 8 | Methodological issues in cancer clinical trials: the comparison of therapies. | 1988 | 2 |
About Gehan Ea
Gehan Ea is a scholar working on Public Health, Environmental and Occupational Health, Hematology, Pulmonary and Respiratory Medicine, Cancer Research and Surgery, having authored 8 papers that have together received 353 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (4 papers), Acute Lymphoblastic Leukemia research (4 papers), Sarcoma Diagnosis and Treatment (3 papers), Cancer Genomics and Diagnostics (3 papers), Hematopoietic Stem Cell Transplantation (2 papers), Radiopharmaceutical Chemistry and Applications (1 paper), Neutropenia and Cancer Infections (1 paper) and Orthopedic Infections and Treatments (1 paper). The work is most often cited by research in Hematology (187 citations), Genetics (45 citations), Pulmonary and Respiratory Medicine (124 citations), Public Health, Environmental and Occupational Health (90 citations) and Emergency Medicine (23 citations). Gehan Ea has collaborated with scholars based in United States. Frequent co-authors include EJ Freireich, KB McCredie, Terry Smith, Gary Spitzer, Burgert Eo, Melvin Tefft, Pritchard Dj, John M. Kissane, Nesbit Me and Thomas D. Miale. Their work appears in journals such as Blood and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.